Samjin Pharm (005500)

Seoul

Currency in KRW

17,790

-650(-3.52%)

Closed·02:29:59

Fair Value

Unlock Value

Day's Range

17,720

18,460

52 wk Range

16,580

25,900

005500 Income Statement

Assess the Samjin Pharm income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 005500 net worth.

Period Ending:

2005

31/12

2006

31/12

2007

31/12

2008

31/12

2009

31/12

2010

31/12

2011

31/12

2012

31/12

2021

31/12

2022

31/12

Total Revenues

aa.aa

200,410.52

201,756.1

185,702.08

250,070.36

274,031.81

Total Revenues Growth

aa.aa

+21.18%

+0.67%

-7.96%

+34.66%

+9.58%

Cost Of Revenues

aa.aa

80,222.41

80,316.01

77,519.87

132,238.37

156,297.39

Gross Profit

aa.aa

120,188.1

121,440.09

108,182.21

117,831.98

117,734.42

Gross Profit Growth

aa.aa

+25.25%

+1.04%

-10.92%

+8.92%

-0.08%

Gross Profit Margin %

aa.aa

59.97%

60.19%

58.26%

47.12%

42.96%

Other Operating Expenses, Total

aa.aa

98,107.81

97,533.42

90,864.57

83,920.56

94,550.1

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+16.85%	-0.59%	-6.84%	-7.64%	+12.67%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,776.31	-	-	2,581.93	3,657.76
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	88,310	97,428.06	90,864.57	79,936.5	89,196.75
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	483.94	105.36	-	587.29	692.07

Operating Income

aa.aa

22,080.29

23,906.67

17,317.64

33,911.43

23,184.32

Operating Income Growth

aa.aa

+84%

+8.27%

-27.56%

+95.82%

-31.63%

EBIT Margin %

aa.aa

11.02%

11.85%

9.33%

13.56%

8.46%

Net Interest Expenses

aa.aa

-1,299.52

-2,049.83

-1,413.54

73.2

-1,609.72

Net Interest Expenses Growth

aa.aa

+8.02%

-57.74%

+31.04%

+105.18%

-2,299.16%

Interest Expense, Total

aa.aa

-2,702.39

-2,431.16

-1,770.22

-141.92

-1,763.24

Interest And Investment Income

aa.aa

1,402.87

381.33

356.69

215.12

153.52

Other Non Operating Expenses, Total

aa.aa

-100.73

-843.25

-149.97

230.65

EBT, Excl. Unusual Items

aa.aa

20,680.04

21,856.84

15,060.86

33,834.65

21,805.25

Gain (Loss) On Sale Of Assets

aa.aa

149.96

1,037.26

500.53

Other Unusual Items, Total

aa.aa

-4,460.04

39.33

0.5

EBT, Incl. Unusual Items

aa.aa

15,652.76

21,856.84

15,060.86

34,911.24

25,226.25

EBT, Incl. Unusual Items Growth

aa.aa

+57.73%

+39.64%

-31.09%

+131.8%

-27.74%

EBT, Incl. Unusual Items Margin

aa.aa

7.81%

10.83%

8.11%

13.96%

9.21%

Income Tax Expense

aa.aa

5,175.57

14,794.38

4,422.42

6,507.08

3,325.33

Net Income to Company

aa.aa

10,477.2

7,062.46

10,638.44

28,404.16

21,900.92

Minority Interest

aa.aa

-7.08

Net Income

aa.aa

10,477.2

7,062.46

10,638.44

28,404.16

21,893.84

Net Income Growth

aa.aa

+48.72%

-32.59%

+50.63%

+167%

-22.92%

Net Income Margin %

aa.aa

5.23%

3.5%

5.73%

11.36%

7.99%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

10,477.2

7,062.46

10,638.44

28,404.16

21,893.84

Basic EPS - Continuing Operations

aa.aa

792.68

542

817

2,308.75

1,727.82

Basic EPS - Continuing Operations Growth

aa.aa

+48.74%

-31.62%

+50.74%

+182.59%

-25.16%

Diluted EPS - Continuing Operations

aa.aa

792.68

542

817

2,308.75

1,727.82

Diluted EPS - Continuing Operations Growth

aa.aa

+48.74%

-31.62%

+50.74%

+182.59%

-25.16%

Basic Weighted Average Shares Outstanding

aa.aa

13.22

13.03

13.02

12.3

12.67

Diluted Weighted Average Shares Outstanding

aa.aa

13.22

13.03

13.02

12.3

12.67

Dividend Per Share

aa.aa

800

Dividend Per Share Growth

aa.aa

+77.12%

EBITDA

aa.aa

24,969.58

27,148.64

21,386.23

41,271.89

33,000.38

EBITDA Growth

aa.aa

+73.95%

+8.73%

-21.23%

+92.98%

-20.04%

EBITDA Margin %

aa.aa

12.46%

13.46%

11.52%

16.5%

12.04%

EBIT

aa.aa

22,080.29

23,906.67

17,317.64

33,911.43

23,184.32

* In Millions of KRW (except for per share items)

FAQ

What was Samjin Pharm’s revenue at year end?

At the end of the last reported fiscal year, Samjin Pharm (005500) recorded total revenue of 274,032 million KRW.

How much revenue did Samjin Pharm report in the most recent quarter?

In its most recent quarterly earnings report, Samjin Pharm posted revenue of 48,915 million KRW.

What was Samjin Pharm’s net income for the year?

For the full year, Samjin Pharm reported net income of 21,894 million KRW.

How much net income did Samjin Pharm post in the last quarter?

In the most recent quarter, Samjin Pharm (005500) posted net income of 5,546 million KRW.

What was Samjin Pharm’s gross profit for the year?

Gross profit for the year was reported at 117,734 million KRW.

How much gross profit did Samjin Pharm generate last quarter?

Samjin Pharm recorded gross profit of 30,561 million KRW in its latest quarterly report.

What was Samjin Pharm’s annual operating income?

For the full year, Samjin Pharm (005500) reported operating income of 23,184 million KRW.

What was Samjin Pharm’s operating income last quarter?

Quarterly operating income was 7,798 million KRW.

What is Samjin Pharm’s most recent gross profit margin?

The latest reported gross profit margin for Samjin Pharm (005500) is 62% million KRW.

What is Samjin Pharm’s most recent net income margin?

Net income margin based on recent financials is 11% million KRW.

What is Samjin Pharm’s most recent EBIT margin?

Samjin Pharm reported an EBIT margin of 16% million KRW based on current figures.

How did Samjin Pharm’s revenue change compared to the previous quarter?

Revenue changed by 4% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Samjin Pharm?

In the latest quarter, gross profit changed by 8% million KRW from the previous quarter.

S&P/TSX

36,359.82

-308.10

-0.84%

S&P/TSX 60

2,142.40

-15.73

-0.73%

US 30

53,372.00

-88.0

-0.16%

US 500

7,702.00

-43.4

-0.56%

S&P 500 VIX

15.70

+0.51

+3.36%

DAX

26,151.69

-186.92

-0.71%

Dollar Index

99.555

+0.021

+0.02%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	71.28	+1.51%	9.66M
Toronto Dominion Bank	169.02	-2.03%	1.61M
RBC	294.79	-1.77%	579.66K
Quebecor B	65.00	-0.70%	2.50M
Bank of Montreal	252.98	-1.58%	561.18K
Celestica Inc.	432.73	-8.22%	315.53K
Cenovus Energy Inc	45.00	+0.99%	2.24M

Name	Last	Chg. %	Vol.
Asep Medical Holdings	0.39	+609.09%	3.00K
Metaguestai	0.03	+200.00%	93.75K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Lithos Energy	0.21	+110.00%	500.00
Martello Tech	0.0100	+100.00%	22.44K
ePlay Digital	0.010	+100.00%	7.00K
Psyched Wellness	0.01	+100.00%	7.50K

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.05	-68.75%	18.17K
Verisante Technology Inc	0.0050	-66.67%	1.00K
Molecule Holdings	0.005	-50.00%	20.11K
Albert Labs International	0.005	-50.00%	1.00K
Canadian Chrome	0.005	-50.00%	5.37M
Playground Ventures	0.010	-50.00%	1.00K
Beckett’s	0.005	-50.00%	131.80K

Trending Stocks

Name	Last	Chg. %	Vol.
HIVE Digital Tech	3.9300	-7.31%	3.21M
Keel Infra	4.84	-7.73%	3.07M
Canadian Natural	68.60	+0.31%	1.34M
Cenovus Energy Inc	45.00	+0.99%	2.24M
Celestica Inc.	432.73	-8.22%	315.53K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaa Aaaaaaaa	130.99	+55.77%	204.04
Aaaaa Aaa	101.79	+46.10%	148.72
Aaaaaaaaaa	30.07	+45.37%	43.71
A Aaaaa Aaaaaaaaaaa	16.97	+45.00%	24.61
Aa Aaaaa Aaa Aaaaaa	5.52	+42.36%	7.86
A Aaaaa A	33.81	+40.85%	47.62
Aaaa Aa	2.845	+40.15%	3.987

Name	Last	Upside	Fair Value
Aaaaaaaaaa Aaaaaaaa	130.99	+55.77%	204.04
Aaaaa Aaa	101.79	+46.10%	148.72
Aaaaaaaaaa	30.07	+45.37%	43.71
A Aaaaa Aaaaaaaaaaa	16.97	+45.00%	24.61
Aa Aaaaa Aaa Aaaaaa	5.52	+42.36%	7.86
A Aaaaa A	33.81	+40.85%	47.62
Aaaa Aa	2.845	+40.15%	3.987

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Samjin Pharm (005500)

005500 Income Statement

FAQ

What was Samjin Pharm’s revenue at year end?

How much revenue did Samjin Pharm report in the most recent quarter?

What was Samjin Pharm’s net income for the year?

How much net income did Samjin Pharm post in the last quarter?

What was Samjin Pharm’s gross profit for the year?

How much gross profit did Samjin Pharm generate last quarter?

What was Samjin Pharm’s annual operating income?

What was Samjin Pharm’s operating income last quarter?

What is Samjin Pharm’s most recent gross profit margin?

What is Samjin Pharm’s most recent net income margin?

What is Samjin Pharm’s most recent EBIT margin?

How did Samjin Pharm’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Samjin Pharm?

Trending Stocks